| LYRAX | VMVAX | LYRAX / VMVAX | |
| Total Expense Ratio | 1.24 | 0.07 | 1,771% |
| Annual Report Gross Expense Ratio | 1.67 | 0.07 | 2,386% |
| Fund Existence | 4 years | 15 years | - |
| Gain YTD | 16.011 | 15.500 | 103% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.31B | 37.2B | 4% |
| Annual Yield % from dividends | 0.00 | 1.81 | - |
| Returns for 1 year | 17.03 | 22.51 | 76% |
| Returns for 3 years | 60.60 | 44.10 | 137% |
| Returns for 5 years | N/A | 46.55 | - |
| Returns for 10 years | N/A | 127.98 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VZGRX | 60.67 | 0.98 | +1.64% |
| Virtus Zevenbergen Innovative Gr Stk R6 | |||
| HDGYX | 40.50 | 0.30 | +0.75% |
| Hartford Dividend and Growth Y | |||
| GPRIX | 14.76 | 0.08 | +0.54% |
| Grandeur Peak Global Reach Instl | |||
| BGEKX | 14.48 | -0.04 | -0.28% |
| Baillie Gifford International Growth K | |||
| NBHCX | 16.44 | -0.07 | -0.42% |
| Neuberger Equity Income C | |||